Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest liver transplant Stories

2008-08-21 18:00:53

COLUMBIA, Md., Aug. 21 /PRNewswire/ -- Israeli et al.,* in an article just published in the peer-reviewed journal Liver Transplantation, have further developed our understanding of the clinical potential of monitoring cell- mediated immunity in pediatric liver-transplant patients post-transplantation. Working in a cooperative group involving several institutions in Petach- Tikva and Tel Aviv in Israel, Israeli and his colleagues focused on the use of the Cylex ImmuKnow assay to monitor...

2008-08-20 15:00:19

NEW YORK, Aug. 20 /PRNewswire-USNewswire/ -- Patients who suffer from severe liver disease and need a liver transplant will no longer have to seek that highly specialized surgery and critically important follow-up care outside the borough of the Bronx. Area patients and their families now have access to this high-quality care locally, without having to travel long distances, as a result of the New York State Department of Health's approval of the first and only liver transplant program in...

2008-07-11 18:00:35

SEATTLE, July 11 /PRNewswire-USNewswire/ -- The Washington state Supreme Court has upheld a Department of Health decision to allow Swedish to establish a new adult liver transplant program on Swedish's First Hill campus. With this formal approval, the first procedures at Swedish could start in early 2009. Swedish originally received approval for its Certificate of Need application to provide liver transplant services in 2004, but it was appealed by University of Washington Medical Center...

2008-07-08 09:01:10

LifeCycle Pharma has announced positive top-line results from a completed Phase II clinical study of LCP-Tacro tablets in stable liver transplant patients which are in line with earlier data announced for stable kidney transplant patients. These new data for LifeCycle Pharma (LCP)-Tacro, a once daily immunosuppression drug to prevent rejection after organ transplantation, demonstrated that LCP-Tacro tablets also have a potential best-in-class profile when compared to the currently marketed...

2008-07-08 03:00:26

LifeCycle Pharma A/S (OMX:LCP) today announced positive top-line results from a completed Phase II clinical study of LCP-Tacro tablets in stable liver transplant patients which are in line with earlier data announced for stable kidney transplant patients. These new data for LCP-Tacro, a once daily immunosuppression drug to prevent rejection after organ transplantation, demonstrated that LCP-Tacro tablets also for stable liver patients have a potential best-in-class profile when compared to...

2008-06-30 06:02:50

LIVER transplant patients will receive special dental care after their operations under a scheme to be launched by NHS Lothian. The patients will receive dental assessments before and after their transplants and advice on how to avoid problems with their teeth. Patients from the Lothians needing dental treatment that can't be provided by their local dentist will have their dental care co- ordinated through the dental unit at the city's Royal Infirmary. Transplant patients are at risk...

2008-06-16 12:01:03

China liver transplant recipients to be registered: Health Ministry SHANGHAI, June 15 (Xinhua) -- The Health Ministry will use mandatory registration of valid personal information for liver transplant patients, officials said. The ministry will implement the China Liver Transplant Registry (CLTR), a compulsory reporting system, said Vice Health Minister Huang Jiefu while attending a transplant meeting held here on Saturday. "The CLTR system can help doctors track the condition of...

2007-08-16 06:16:41

By Stewart, Susan Context.-Pulmonary infections are common and often life- threatening in solid organ and stem cell transplant recipients. Understanding their pathology is critical to making improvements in care and survival as well as in surgical techniques, immunosuppression management, prophylaxis, and treatment. Pulmonary infections are particularly common and serious in the susceptible population of lung transplant recipients. Objective.-To summarize recent updates in the field for...

2005-11-11 16:29:52

LOS ANGELES (Reuters) - A Southern California hospital has suspended its liver transplant program after the Los Angeles Times reported 32 patients awaiting transplants had died while the facility turned down scores of donor organs. The University of California at Irvine Medical Center in Orange, south of Los Angeles, issued a statement late on Thursday saying the U.S. government had revoked its certification of the liver transplant program, denying further Medicare reimbursements for...

2005-10-06 17:32:03

CHAPEL HILL -- An estimated 20 percent of people with chronic hepatitis C who receive a liver transplant will develop advanced cirrhosis, scarring of the new organ severe enough to impair its ability to function normally within five years of transplantation. A new study from the University of North Carolina at Chapel Hill School of Medicine may have found a way to identify those at greatest risk, thereby allowing doctors to decide who should receive treatment that could save the transplanted...